Prophylactic Proton Pump Inhibition for Esophageal Protection in Lung Radiation Therapy
Status:
NOT_YET_RECRUITING
Trial end date:
2032-10-02
Target enrollment:
Participant gender:
Summary
A randomized controlled trial to assess the impact of prophylactic proton pump inhibitor use to improve esophagitis in lung cancer patients undergoing radiation. Patients will be randomized into a standard of care arm or the prophylactic proton pump (daily) arm.
Phase:
PHASE2
Details
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's